中信银行 reported revenue of ¥109.41B for the period ended 2026-06-30, +3.1% year on year. Net income was ¥38.18B, a 34.9% net margin on a 100.0% gross margin. The largest revenue line is 公司银行业务 at 46% of the total. Free cash flow for the period was ¥40.77B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥109.41B | +3.1% |
| Gross profit | ¥109.41B | — |
| Operating income | ¥45.80B | — |
| Net income | ¥38.18B | +3.0% |
| Gross margin | 100.0% | Net margin 34.9% |
| Revenue Q/Q | +0.2% | — |
| Segment | Revenue | Share |
|---|---|---|
| 公司银行业务 | ¥50.53B | 46.2% |
| 零售银行业务 | ¥40.24B | 36.8% |
| 金融市场业务 | ¥17.49B | 16.0% |
| 其他业务及未分配项目 | ¥1.14B | 1.0% |
| Item | Amount | % of revenue |
|---|---|---|
| SG&A | ¥27.86B | 25.5% |
| Tax & other | ¥7.62B | 7.0% |
| Item | Amount |
|---|---|
| Total assets | ¥10,383.84B |
| Total liabilities | ¥9,493.04B |
| Shareholders' equity | ¥890.80B |
| Equity / assets | 8.6% |
| Operating cash flow | ¥42.80B |
| Capital expenditure | ¥2.04B |
| Free cash flow | ¥40.77B |
| Cash conversion (OCF / net income) | 605% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中科曙光 ・ 药明康德 ・ 合盛硅业 ・ 海天味业 ・ 华勤技术 ・ 今世缘 ・ 万泰生物 ・ 豪威集团 ・ 华友钴业 ・ 瑞芯微 ・ 兆易创新 ・ 洛阳钼业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies